2024), punicalagin (Al-Khawalde et al
Chapters: 00:00 Intro With Peter Magic (Janoshik Labs) 02:40 How Janoshik Started 09:09 DEA Raid & Dorm Room Lab Story 11:49 Fake Steroids & Underground Labs 14:17 Peptide Testing & Empty Vials 19:59 Why America Dominates The Market 23:31 Peptide Purity Explained 27:16 Endotoxins, Heavy Metals & Safety 35:36 Factory Mistakes & Contamination Issues 43:44 Angry Customers & Lab Mistakes 46:38 Peptide Regulations & The Future 50:34 The Crazy Customs Dildo Story 55:05 Why Testing Labs Cant Operate in America 01:03:19 The Future of Janoshik Labs We cover: What Janoshik actually does World's largest commercial analytical chemistry lab for hormones and peptides Over 20,000 sq ft, 40+ employees, now receiving 1,000+ samples per day Started organically from a dorm room at 16 years old no marketing, no investors Grown 50% in the last three months alone What's actually in your peptides Roughly 1 in 20 samples is either the wrong compound or so underdosed it's useless Recent surge of completely empty vials no active compound whatsoever Affects all peptides: BPC, GHK, Sema, Reta, and more Empty vials coming mostly from distributors vetting new suppliers most never reach consumers "Bioglutide" a completely made-up molecule still being sold and always tests as something else What actually matters when testing Identity and dose: by far the most valuable tests you can run Heavy metals: virtually never an issue in peptides don't fall for scare tactics Endotoxins: previously considered unnecessary, but recent contaminated batches causing local reactions have changed that view 100% purity is physically impossible anyone claiming it is using questionable methodology Pharma standard for HGH is 89% purity market standard runs 9296% The HGH reality HGH is 191 amino acids far more complex and harder to keep pure than short-chain peptides Tested over 99% pure HGH exists but is extremely rare Fancy branded ampoules (like Bayer Primobolan) test as pure oil over 90% of the time the counterfeiting is near-perfect Where the business comes from ~2/3 of revenue from the US biggest consumer market and peptide culture ~20% from China manufacturers using Janoshik to verify their own products 60,000+ individual US clients vs
Swati Pradhan is crucial to confirm suitability and address any potential contraindications
A research study to look into the long-term effect on weight loss of CagriSema in people with obesity (NCT06780449) Summary: This is an ongoing Phase 3 trial (as of current knowledge) designed to evaluate the long-term efficacy and safety of once-weekly CagriSema in people living with obesity
FDA - Certain Bulk Drug Substances for Use in Compounding: Lists BPC-157 with potential safety risks and lack of sufficient information
